July 6, 2018

Please reload

Recent Posts

FDA Comments on Recently Released Rare Disease Guidance for Industry

September 16, 2015

Jonathan Goldsmith, M.D., F.A.C.P., FDA’s Associate Director, Rare Diseases Program, Center for Drug Evaluation and Research, comments on the recently...

1/2
Please reload

Featured Posts

A Year in Review: 2015 505(b)(2) NDA Approvals

February 8, 2016

Camargo recently published a thorough review of the 2015 505(b)(2) NDA approvals.  There are a lot of interesting statistics to glean from this summary.  With 44 505(b)(2) approvals in 2015, one thing is clear: drug repurposing continues to play an important role in drug development.  

 

To read more, check out the following link: http://blog.camargopharma.com/index.php/2016/02/04/2015-505b2-nda-approvals/

 

 

Please reload

Patagonia Pharmaceuticals, LLC

50 Tice Blvd, Suite A26

Woodcliff Lake, NJ 07677

For more info: info@patagoniarx.com

© 2019 by Patagonia Pharmaceuticals, LLC